Hans Orskov

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Chemicals & Drugs

Living Beings

Anatomy

Kidney

Disorders

Concepts & Ideas

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Nielsen Jannik Kruse; Djurhuus Christian Born; Gravholt Claus Højbjerg; Carus Andreas Christiansen; Granild-Jensen Jacob; Orskov Hans; Christiansen Jens Sandahl
Continuous glucose monitoring in interstitial subcutaneous adipose tissue and skeletal muscle reflects excursions in cerebral cortex.
Espelund Ulrick; Hansen Troels Krarup; Højlund Kurt; Beck-Nielsen Henning; Clausen Jes Thorn; Hansen Birgit Sehested; Orskov Hans; Jørgensen Jens Otto Lunde; Frystyk Jan
Fasting unmasks a strong inverse association between ghrelin and cortisol in serum: studies in obese and normal-weight subjects.
Chen Jian-Wen; Højlund Kurt; Beck-Nielsen Henning; Sandahl Christiansen Jens; Orskov Hans; Frystyk Jan
Free rather than total circulating insulin-like growth factor-I determines the feedback on growth hormone release in normal subjects.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Hans Orskov (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2005: Nielsen Jannik Kruse; Djurhuus Christian Born; Gravholt Claus Højbjerg; Carus Andreas Christiansen; Granild-Jensen Jacob; Orskov Hans; Christiansen Jens Sandahl
Continuous glucose monitoring in interstitial subcutaneous adipose tissue and skeletal muscle reflects excursions in cerebral cortex.
Diabetes 2005;54(6):1635-9.
2005: Espelund Ulrick; Hansen Troels Krarup; Højlund Kurt; Beck-Nielsen Henning; Clausen Jes Thorn; Hansen Birgit Sehested; Orskov Hans; Jørgensen Jens Otto Lunde; Frystyk Jan
Fasting unmasks a strong inverse association between ghrelin and cortisol in serum: studies in obese and normal-weight subjects.
The Journal of clinical endocrinology and metabolism 2005;90(2):741-6.
2005: Chen Jian-Wen; Højlund Kurt; Beck-Nielsen Henning; Sandahl Christiansen Jens; Orskov Hans; Frystyk Jan
Free rather than total circulating insulin-like growth factor-I determines the feedback on growth hormone release in normal subjects.
The Journal of clinical endocrinology and metabolism 2005;90(1):366-71.
2005: Fisker Sanne; Andersen Marianne; Orskov Hans
Diagnosis of growth hormone deficiency.
Frontiers of hormone research 2005;33():68-85.
2004: Skjaerbaek Christian; Frystyk Jan; Orskov Hans; Flyvbjerg Allan
Free IGF-I, IGFBP-1, and the binary complex of IGFBP-1 and IGF-I are increased during human pregnancy.
Hormone research 2004;62(5):215-20.
2003: Jørgensen J O L; Krag M; Kanaley J; Møller J; Hansen T K; Møller N; Christiansen J S; Orskov H
Exercise, hormones, and body temperature. regulation and action of GH during exercise.
Journal of endocrinological investigation 2003;26(9):838-42.
2001: Gravholt C H; Frystyk J; Flyvbjerg A; Orskov H; Christiansen J S
Reduced free IGF-I and increased IGFBP-3 proteolysis in Turner syndrome: modulation by female sex steroids.
American journal of physiology. Endocrinology and metabolism 2001;280(2):E308-14.
2000: Andersen N B; Andreassen T T; Orskov H; Oxlund H
Growth hormone and mild exercise in combination increases markedly muscle mass and tetanic tension in old rats.
European journal of endocrinology / European Federation of Endocrine Societies 2000;143(3):409-18.
2000: Kaal A; Orskov H; Nielsen S; Pedroncelli A M; Lancranjan I; Marbach P; Weeke J
Occurrence and effects of octreotide antibodies during nasal, subcutaneous and slow release intramuscular treatment.
European journal of endocrinology / European Federation of Endocrine Societies 2000;143(3):353-61.
2000: Vahl N; Juul A; Jørgensen J O; Orskov H; Skakkebaek N E; Christiansen J S
Continuation of growth hormone (GH) replacement in GH-deficient patients during transition from childhood to adulthood: a two-year placebo-controlled study.
The Journal of clinical endocrinology and metabolism 2000;85(5):1874-81.
2000: Skjaerbaek C; Frystyk J; Kaal A; Laursen T; Møller J; Weeke J; Jørgensen J O; Sandahl Christiansen J; Orskov H
Circadian variation in serum free and total insulin-like growth factor (IGF)-I and IGF-II in untreated and treated acromegaly and growth hormone deficiency.
Clinical endocrinology 2000;52(1):25-33.
1999: Fisker S; Jorgensen J O; Vahl N; Orskov H; Christiansen J S
Impact of gender and androgen status on IGF-I levels in normal and GH-deficient adults.
European journal of endocrinology / European Federation of Endocrine Societies 1999;141(6):601-8.
1999: Frystyk J; Ivarsen P; Skjaerbaek C; Flyvbjerg A; Pedersen E B; Orskov H
Serum-free insulin-like growth factor I correlates with clearance in patients with chronic renal failure.
Kidney international 1999;56(6):2076-84.
1999: Frystyk J; Skjaerbaek C; Vestbo E; Fisker S; Orskov H
Circulating levels of free insulin-like growth factors in obese subjects: the impact of type 2 diabetes.
Diabetes/metabolism research and reviews 1999;15(5):314-22.
1999: Nielsen B; Gronbaek H; Osterby R; Orskov H; Flyvbjerg A
The calcium channel blocker nitrendipine attenuates renal and glomerular hypertrophy in diabetic rats.
Experimental nephrology 1999;7(3):242-50.
1999: Heuck C; Skjaerbaek C; Orskov H; Wolthers O D
Circadian variation in serum free ultrafiltrable insulin-like growth factor I concentrations in healthy children.
Pediatric research 1999;45(5 Pt 1):733-6.
1999: Frystyk J; Hussain M; Skjaerbaek C; Pørksen N; Froesch E R; Orskov H
The pharmacokinetics of free insulin-like growth factor-I in healthy subjects.
Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society 1999;9(2):150-6.
1999: Johansen P B; Nowak J; Skjaerbaek C; Flyvbjerg A; Andreassen T T; Wilken M; Orskov H
Ipamorelin, a new growth-hormone-releasing peptide, induces longitudinal bone growth in rats.
Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society 1999;9(2):106-13.
1999: Skjaerbaek C; Frystyk J; Grøfte T; Flyvbjerg A; Lewitt M S; Baxter R C; Orskov H
Serum free insulin-like growth factor-I is dose-dependently decreased by methylprednisolone and related to body weight changes in rats.
Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society 1999;9(1):74-80.
1999: Ebdrup L; Fisker S; Sørensen H H; Ranke M B; Orskov H
Variety in growth hormone determinations due to use of different immunoassays and to the interference of growth hormone-binding protein.
Hormone research 1999;51 Suppl 1():20-6.
1998: Fisker S; Jørgensen J O; Orskov H; Christiansen J S
GH stimulation tests: evaluation of GH responses to heat test versus insulin-tolerance test.
European journal of endocrinology / European Federation of Endocrine Societies 1998;139(6):605-10.
1998: Frystyk J; Grønbaek H; Skjaerbaek C; Flyvbjerg A; Orskov H; Baxter R C
Developmental changes in serum levels of free and total insulin-like growth factor I (IGF-I), IGF-binding protein-1 and -3, and the acid-labile subunit in rats.
Endocrinology 1998;139(10):4286-92.
1998: Fisker S; Ebdrup L; Orskov H
Influence of growth hormone binding protein on growth hormone estimation in different immunoassays.
Scandinavian journal of clinical and laboratory investigation 1998;58(5):373-81.
1998: Grønbaek H; Skjaerbaek C; Orskov H; Flyvbjerg A
Effect of immunosuppression on kidney and serum insulin-like growth factor-I (IGF-I), IGF binding proteins, and renal growth following unilateral nephrectomy in rats.
Metabolism: clinical and experimental 1998;47(7):817-23.
1998: Skjaerbaek C; Frystyk J; Orskov H; Kissmeyer-Nielsen P; Jensen M B; Laurberg S; Møller N; Flyvbjerg A
Differential changes in free and total insulin-like growth factor I after major, elective abdominal surgery: the possible role of insulin-like growth factor-binding protein-3 proteolysis.
The Journal of clinical endocrinology and metabolism 1998;83(7):2445-9.
1998: Frystyk J; Skjaerbaek C; Zapf J; Orskov H
Increased levels of circulating free insulin-like growth factors in patients with non-islet cell tumour hypoglycaemia.
Diabetologia 1998;41(5):589-94.
1998: Fisker S; Vahl N; Hansen T B; Jørgensen J O; Hagen C; Orskov H; Christiansen J S
Growth hormone (GH) substitution for one year normalizes elevated GH-binding protein levels in GH-deficient adults secondary to a reduction in body fat. A placebo-controlled trial.
Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society 1998;8(2):105-12.
1998: Jørgensen J O; Vahl N; Hansen T B; Skjaerbaek C; Fisker S; Orskov H; Hagen C; Christiansen J S
Determinants of serum insulin-like growth factor I in growth hormone deficient adults as compared to healthy subjects.
Clinical endocrinology 1998;48(4):479-86.
1998: Skjaerbaek C; Kaal A; Møller J; Vahl N; Weeke J; Orskov H; Flyvbjerg A
No effect of growth hormone on serum insulin-like growth factor binding protein-3 proteolysis.
The Journal of clinical endocrinology and metabolism 1998;83(4):1206-10.
1998: Oxlund H; Andersen N B; Ortoft G; Orskov H; Andreassen T T
Growth hormone and mild exercise in combination markedly enhance cortical bone formation and strength in old rats.
Endocrinology 1998;139(4):1899-904.
1998: Fisker S; Jørgensen J O; Orskov H; Christiansen J S
L-arginine and insulin-tolerance tests in the diagnosis of adult growth hormone deficiency: influence of confounding factors.
Clinical endocrinology 1998;48(1):109-15.
1998: Grønbaek H; Vogel I; Osterby R; Lancranjan I; Flyvbjerg A; Orskov H
Effect of octreotide, captopril or insulin on renal changes and UAE in long-term experimental diabetes.
Kidney international 1998;53(1):173-80.
1997: Møller N; Orskov H
Does IGF-I therapy in insulin-dependent diabetes mellitus limit complications?
Lancet 1997;350(9086):1188-9.
1997: Frystyk J; Hussain M; Skjaerbaek C; Schmitz O; Christiansen J S; Froesch E R; Orskov H
Serum free IGF-I during a hyperinsulinemic clamp following 3 days of administration of IGF-I vs. saline.
The American journal of physiology 1997;273(3 Pt 1):E507-13.
1997: Frystyk J; Grøfte T; Skjaerbaek C; Orskov H
The effect of oral glucose on serum free insulin-like growth factor-I and -II in health adults.
The Journal of clinical endocrinology and metabolism 1997;82(9):3124-7.
1997: Skjaerbaek C; Vahl N; Frystyk J; Hansen T B; Jørgensen J O; Hagen C; Christiansen J S; Orskov H
Serum free insulin-like growth factor-I in growth hormone-deficient adults before and after growth hormone replacement.
European journal of endocrinology / European Federation of Endocrine Societies 1997;137(2):132-7.
1997: Fisker S; Vahl N; Hansen T B; Jørgensen J O; Hagen C; Orskov H; Christiansen J S
Serum leptin is increased in growth hormone-deficient adults: relationship to body composition and effects of placebo-controlled growth hormone therapy for 1 year.
Metabolism: clinical and experimental 1997;46(7):812-7.
1997: Vahl N; Jørgensen J O; Skjaerbaek C; Veldhuis J D; Orskov H; Christiansen J S
Abdominal adiposity rather than age and sex predicts mass and regularity of GH secretion in healthy adults.
The American journal of physiology 1997;272(6 Pt 1):E1108-16.
1997: Grønbaek H; Volmers P; Bjørn S F; Osterby R; Orskov H; Flyvbjerg A
Effect of GH/IGF-I deficiency on long-term renal changes and urinary albumin excretion in diabetic dwarf rats.
The American journal of physiology 1997;272(5 Pt 1):E918-24.
1997: Grøfte T; Wolthers T; Jensen S A; Møller N; Jørgensen J O; Tygstrup N; Orskov H; Vilstrup H
Effects of growth hormone and insulin-like growth factor-I singly and in combination on in vivo capacity of urea synthesis, gene expression of urea cycle enzymes, and organ nitrogen contents in rats.
Hepatology (Baltimore, Md.) 1997;25(4):964-9.
1997: Fisker S; Kaal A; Montini M; Pedroncelli A; Pagani G; Orskov H
Growth hormone binding protein and growth hormone availability in acromegalic patients treated with long-acting octreotide (Sandostatin-LAR).
European journal of endocrinology / European Federation of Endocrine Societies 1997;136(1):61-6.
1997: Grønboek H; Nielsen B; Flyvbjerg A; Orskov H
Effect of graded renal ablation on kidney and serum insulin-like growth factor-I (IGF-I) and IGF binding proteins in rats: relation to compensatory renal growth.
Metabolism: clinical and experimental 1997;46(1):29-35.
1997: Fisker S; Vahl N; Jørgensen J O; Christiansen J S; Orskov H
Abdominal fat determines growth hormone-binding protein levels in healthy nonobese adults.
The Journal of clinical endocrinology and metabolism 1997;82(1):123-8.
1996: Skjaerbaek C; Frystyk J; Møller J; Christiansen J S; Orskov H
Free and total insulin-like growth factors and insulin-like growth factor binding proteins during 14 days of growth hormone administration in healthy adults.
European journal of endocrinology / European Federation of Endocrine Societies 1996;135(6):672-7.
1996: Eriksen U H; Amtorp O; Bagger J P; Emanuelsson H; Foegh M; Saunamäki K I; Schaeffer M; Thayssen P; Orskov H; Kuntz R E; Popma J J
[Angiopeptin versus placebo for reductin of restenosis after PTCA treatment. A randomized, double-blind study]
Ugeskrift for laeger 1996;158(46):6605-8.
1996: Frystyk J; Skjaerbaek C; Alexander N; Emanuelsson H; Suryapranata H; Beyer H; Foegh M; Orskov H
Lanreotide reduces serum free and total insulin-like growth factor-I after angioplasty.
Circulation 1996;94(10):2465-71.
1996: Grønbaek H; Nielsen B; Frystyk J; Flyvbjerg A; Orskov H
Effect of lanreotide on local kidney IGF-I and renal growth in experimental diabetes in the rat.
Experimental nephrology 1996;4(5):295-303.
1996: Fisker S; Frystyk J; Skriver L; Vestbo E; Ho K K; Orskov H
A simple, rapid immunometric assay for determination of functional and growth hormone-occupied growth hormone-binding protein in human serum.
European journal of clinical investigation 1996;26(9):779-85.
1996: Marshall S M; Hansen K W; Osterby R; Frystyk J; Orskov H; Flyvbjerg A
Effects of heparin on renal morphology and albuminuria in experimental diabetes.
The American journal of physiology 1996;271(2 Pt 1):E326-32.
1996: Orskov H
Somatostatin, growth hormone, insulin-like growth factor-1, and diabetes: friends or foes?
Metabolism: clinical and experimental 1996;45(8 Suppl 1):91-5.
1996: Wolthers T; Grøftne T; Møller N; Christiansen J S; Orskov H; Weeke J; Jørgensen J O
Calorigenic effects of growth hormone: the role of thyroid hormones.
The Journal of clinical endocrinology and metabolism 1996;81(4):1416-9.
1995: Frystyk J; Dinesen B; Orskov H
Non-competitive time-resolved immunofluorometric assays for determination of human insulin-like growth factor I and II.
Growth regulation 1995;5(4):169-76.
1995: Flyvbjerg A; Schuller A G; van Neck J W; Groffen C; Orskov H; Drop S L
Stimulation of hepatic insulin-like growth factor-binding protein-1 and -3 gene expression by octreotide in rats.
The Journal of endocrinology 1995;147(3):545-51.
1995: Grønbaek H; Nielsen B; Frystyk J; Orskov H; Flyvbjerg A
Effect of octreotide on experimental diabetic renal and glomerular growth: importance of early intervention.
The Journal of endocrinology 1995;147(1):95-102.
1995: Frystyk J; Vestbo E; Skjaerbaek C; Mogensen C E; Orskov H
Free insulin-like growth factors in human obesity.
Metabolism: clinical and experimental 1995;44(10 Suppl 4):37-44.
1995: Møller N; Jørgensen J O; Møller J; Orskov L; Ovesen P; Schmitz O; Christiansen J S; Orskov H
Metabolic effects of growth hormone in humans.
Metabolism: clinical and experimental 1995;44(10 Suppl 4):33-6.
1995: Jørgensen J O; Møller N; Wolthers T; Møller J; Grøfte T; Vahl N; Fisker S; Orskov H; Christiansen J S
Fuel metabolism in growth hormone-deficient adults.
Metabolism: clinical and experimental 1995;44(10 Suppl 4):103-7.
1995: Eriksen U H; Amtorp O; Bagger J P; Emanuelsson H; Foegh M; Henningsen P; Saunamäki K; Schaeffer M; Thayssen P; Orskov H
Randomized double-blind Scandinavian trial of angiopeptin versus placebo for the prevention of clinical events and restenosis after coronary balloon angioplasty.
American heart journal 1995;130(1):1-8.
1995: Jørgensen J O; Pedersen S B; Børglum J; Frystyk J; Ho K K; Christiansen J S; Orskov H; Blum W F; Richelsen B
Serum concentrations of insulin-like growth factors (IGFs), IGF binding proteins 1 and 3 and growth hormone binding protein in obese women and the effects of growth hormone administration: a double-blind, placebo-controlled study.
European journal of endocrinology / European Federation of Endocrine Societies 1995;133(1):65-70.
1995: Grønbaek H; Skjaerbaek C; Nielsen B; Frystyk J; Foegh M L; Flyvbjerg A; Orskov H
Growth hormone and insulin-like growth factor-I: a suggested role in renal transplantation and graft vessel disease.
Transplantation proceedings 1995;27(3):2133-6.
1995: Møller N; Bagger J P; Schmitz O; Jørgensen J O; Ovesen P; Møller J; Alberti K G; Orskov H
Somatostatin enhances insulin-stimulated glucose uptake in the perfused human forearm.
The Journal of clinical endocrinology and metabolism 1995;80(6):1789-93.
1995: Nielsen S; Schmitz O; Orskov H; Mogensen C E
Similar insulin sensitivity in NIDDM patients with normo- and microalbuminuria.
Diabetes care 1995;18(6):834-42.
1995: Grønbaek H; Frystyk J; Orskov H; Flyvbjerg A
Effect of sodium selenite on growth, insulin-like growth factor-binding proteins and insulin-like growth factor-I in rats.
The Journal of endocrinology 1995;145(1):105-12.
1995: Grønbaek H; Nielsen B; Osterby R; Harris A; Orskov H; Flyvbjerg A
Effect of octreotide and insulin on manifest renal and glomerular hypertrophy and urinary albumin excretion in long-term experimental diabetes in rats.
Diabetologia 1995;38(2):135-44.
1994: Jørgensen J O; Møller J; Laursen T; Orskov H; Christiansen J S; Weeke J
Growth hormone administration stimulates energy expenditure and extrathyroidal conversion of thyroxine to triiodothyronine in a dose-dependent manner and suppresses circadian thyrotrophin levels: studies in GH-deficient adults.
Clinical endocrinology 1994;41(5):609-14.
1994: Frystyk J; Skjaerbaek C; Dinesen B; Orskov H
Free insulin-like growth factors (IGF-I and IGF-II) in human serum.
FEBS letters 1994;348(2):185-91.
1994: Schmitz O; Pedersen S B; Mengel A; Pørksen N; Bak J; Møller N; Richelsen B; Alberti K G; Butler P C; Orskov H
Augmented effect of short-term pulsatile versus continuous insulin delivery on lipid metabolism but similar effect on whole-body glucose metabolism in obese subjects.
Metabolism: clinical and experimental 1994;43(7):842-6.
1994: Howell M; Orskov H; Frystyk J; Flyvbjerg A; Grønbaek H; Foegh M
Lanreotide, a somatostatin analogue, reduces insulin-like growth factor I accumulation in proliferating aortic tissue in rabbits in vivo. A preliminary study.
European journal of endocrinology / European Federation of Endocrine Societies 1994;130(4):422-5.
1994: Gøtzsche L B; Orskov H
Cardiac triiodothyronine nuclear receptor binding capacities in amiodarone-treated, hypo- and hyperthyroid rats.
European journal of endocrinology / European Federation of Endocrine Societies 1994;130(3):281-90.
1994: Ovesen P; Ingerslev H J; Orskov H; Ledet T
Effect of growth hormone on steroidogenesis, insulin-like growth factor-I (IGF-I) and IGF-binding protein-1 production and DNA synthesis in cultured human luteinized granulosa cells.
The Journal of endocrinology 1994;140(2):313-9.
1994: Wolthers T; Grøfte T; Flyvbjerg A; Frystyk J; Vilstrup H; Orskov H; Foegh M
Dose-dependent stimulation of insulin-like growth factor-binding protein-1 by lanreotide, a somatostatin analog.
The Journal of clinical endocrinology and metabolism 1994;78(1):141-4.
1994: Orskov H; Wolthers T; Grøfte T; Flyvbjerg A; Vilstrup H; Hamberg O
Somatostatin-stimulated insulin-like growth factor binding protein-1 release is abolished by hyperinsulinemia.
The Journal of clinical endocrinology and metabolism 1994;78(1):138-40.
1993: Flyvbjerg A; Nielsen S; Sheikh M I; Jacobsen C; Orskov H; Christensen E I
Luminal and basolateral uptake and receptor binding of IGF-I in rabbit renal proximal tubules.
The American journal of physiology 1993;265(5 Pt 2):F624-33.
1993: Møller J; Jørgensen J O; Lauersen T; Frystyk J; Naeraa R W; Orskov H; Christiansen J S
Growth hormone dose regimens in adult GH deficiency: effects on biochemical growth markers and metabolic parameters.
Clinical endocrinology 1993;39(4):403-8.
1993: Weeke J; Orskov H; Christensen S E; Kaal A; Skjaerbaek C; Illum P; Jørgensen J; Lund E; Haubek A; Poulsen J H
[Long-term treatment with octreotide of patients with acromegaly]
Ugeskrift for laeger 1993;155(34):2592-8.
1993: Bøtker H E; Møller N; Ovesen P; Mengel A; Schmitz O; Orskov H; Bagger J P
Insulin resistance in microvascular angina (syndrome X)
Lancet 1993;342(8864):136-40.
1993: Orskov H; Flyvbjerg A; Frystyk J; Grønbaek H; Foegh M; Harris A G
IGF-1 and acute renal hypertrophy: inhibition by somatostatin analogues.
Transplantation proceedings 1993;25(2):2061-2.
1993: Marshall S M; Flyvbjerg A; Jørgensen K D; Weeke J; Orskov H
Effects of growth hormone and thyroxine on kidney insulin-like growth factor-I and renal growth in hypophysectomized rats.
The Journal of endocrinology 1993;136(3):399-406.
1993: Schmitz O; Orskov L; Lund S; Møller N; Christiansen J S; Orskov H
Glucose metabolism in chronic renal failure with reference to GH treatment of uremic children.
The Journal of pediatric endocrinology 1993;6(1):53-9.
1992: Harris A G; Weeke J; Christensen S E; Kaal A; Illum P; Orskov H
Preliminary results with Sandostatin nasal powder in acromegalic patients.
Metabolism: clinical and experimental 1992;41(9 Suppl 2):72-5.
1992: Orskov H; Flyvbjerg A; Frystyk J; Ledet T; Møller N; Christensen S E; Harris A G
Octreotide and diabetes: theoretical and experimental aspects.
Metabolism: clinical and experimental 1992;41(9 Suppl 2):66-71.
1992: Christensen S E; Weeke J; Orskov H; Kaal A; Lund E; Jørgensen J; Harris A G
Long-term efficacy and tolerability of octreotide treatment in acromegaly.
Metabolism: clinical and experimental 1992;41(9 Suppl 2):44-50.
1992: Weeke J; Christensen S E; Orskov H; Kaal A; Pedersen M M; Illum P; Harris A G
A randomized comparison of intranasal and injectable octreotide administration in patients with acromegaly.
The Journal of clinical endocrinology and metabolism 1992;75(1):163-9.
1992: Flyvbjerg A; Frystyk J; Osterby R; Orskov H
Kidney IGF-I and renal hypertrophy in GH-deficient diabetic dwarf rats.
The American journal of physiology 1992;262(6 Pt 1):E956-62.
1992: Flyvbjerg A; Marshall S M; Frystyk J; Rasch R; Bornfeldt K E; Arnqvist H; Jensen P K; Pallesen G; Orskov H
Insulin-like growth factor I in initial renal hypertrophy in potassium-depleted rats.
The American journal of physiology 1992;262(6 Pt 2):F1023-31.
1992: Flyvbjerg A; Kessler U; Dorka B; Funk B; Orskov H; Kiess W
Transient increase in renal insulin-like growth factor binding proteins during initial kidney hypertrophy in experimental diabetes in rats.
Diabetologia 1992;35(6):589-93.
1992: Christensen S E; Weeke J; Kaal A; Harris A G; Orskov H
SMS 201-995 and thyroid function in acromegaly: acute, intermediate and long-term effects.
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et métabolisme 1992;24(5):237-9.
1992: Flyvbjerg A; Marshall S M; Frystyk J; Hansen K W; Harris A G; Orskov H
Octreotide administration in diabetic rats: effects on renal hypertrophy and urinary albumin excretion.
Kidney international 1992;41(4):805-12.
1992: Dørup I; Flyvbjerg A; Everts M E; Orskov H
Effects of growth hormone on growth and muscle Na(+)-K+ pump concentration in K(+)-deficient rats.
The American journal of physiology 1992;262(4 Pt 1):E511-7.
1991: Flyvbjerg A; Bornfeldt K E; Orskov H; Arnqvist H J
Effect of insulin-like growth factor I infusion on renal hypertrophy in experimental diabetes mellitus in rats.
Diabetologia 1991;34(10):715-20.
1991: Marshall S M; Flyvbjerg A; Frystyk J; Korsgaard L; Orskov H
Renal insulin-like growth factor I and growth hormone receptor binding in experimental diabetes and after unilateral nephrectomy in the rat.
Diabetologia 1991;34(9):632-9.
1991: Orskov H; Christensen S E; Weeke J; Kaal A; Harris A G
Effects of antibodies against octreotide in two patients with acromegaly.
Clinical endocrinology 1991;34(5):395-8.
1991: Flyvbjerg A; Jørgensen K D; Marshall S M; Orskov H
Inhibitory effect of octreotide on growth hormone-induced IGF-I generation and organ growth in hypophysectomized rats.
The American journal of physiology 1991;260(4 Pt 1):E568-74.
1991: Flyvbjerg A; Mogensen C E; Osterby R; Orskov H
Renal hypertrophy in experimental diabetes.
The Journal of diabetic complications 1991;5(2-3):62-4.
1991: Lund E; Jørgensen J; Christensen S E; Weeke J; Orskov H; Harris A G
Reduction in sella turcica volume. An effect of long-term treatment with the somatostatin analogue, SMS 201-995, in acromegalic patients.
Neuroradiology 1991;33(2):162-4.
1990: Flyvbjerg A; Bornfeldt K E; Marshall S M; Arnqvist H J; Orskov H
Kidney IGF-I mRNA in initial renal hypertrophy in experimental diabetes in rats.
Diabetologia 1990;33(6):334-8.
1990: Pedersen M M; Christensen S E; Christiansen J S; Pedersen E B; Mogensen C E; Orskov H
Acute effects of a somatostatin analogue on kidney function in type 1 diabetic patients.
Diabetic medicine : a journal of the British Diabetic Association 1990;7(4):304-9.
1990: Flyvbjerg A; Orskov H
Kidney tissue insulin-like growth factor I and initial renal growth in diabetic rats: relation to severity of diabetes.
Acta endocrinologica 1990;122(3):374-8.
1990: Møller N; Jørgensen J O; Schmitz O; Møller J; Christiansen J; Alberti K G; Orskov H
Effects of a growth hormone pulse on total and forearm substrate fluxes in humans.
The American journal of physiology 1990;258(1 Pt 1):E86-91.
1990: Jørgensen J O; Møller N; Lauritzen T; Alberti K G; Orskov H; Christiansen J S
Evening versus morning injections of growth hormone (GH) in GH-deficient patients: effects on 24-hour patterns of circulating hormones and metabolites.
The Journal of clinical endocrinology and metabolism 1990;70(1):207-14.
1989: Thuesen L; Christensen S E; Weeke J; Orskov H; Henningsen P
The cardiovascular effects of octreotide treatment in acromegaly: an echocardiographic study.
Clinical endocrinology 1989;30(6):619-25.
1989: Flyvbjerg A; Frystyk J; Thorlacius-Ussing O; Orskov H
Somatostatin analogue administration prevents increase in kidney somatomedin C and initial renal growth in diabetic and uninephrectomized rats.
Diabetologia 1989;32(4):261-5.
1989: Orskov L; Schmitz O; Jørgensen J O; Arnfred J; Abildgaard N; Christiansen J S; Alberti K G; Orskov H
Influence of growth hormone on glucose-induced glucose uptake in normal men as assessed by the hyperglycemic clamp technique.
The Journal of clinical endocrinology and metabolism 1989;68(2):276-82.
1988: Arnfred J; Schmitz O; Hother-Nielsen O; Orskov C; Beck-Nielsen H; Hermansen K; Christiansen J S; Alberti K G; Orskov H
Marked impairment of the effect of hyperglycaemia on glucose uptake and glucose production in insulin-dependent diabetes.
Diabetic medicine : a journal of the British Diabetic Association 1988;5(8):755-60.
1988: Hermansen K; Schmitz O; Boye N; Christensen C K; Christiansen J S; Alberti K G; Orskov H; Mogensen C E
Glucagon responses to intravenous arginine and oral glucose in insulin-dependent diabetic patients during six months conventional or continuous subcutaneous insulin infusion.
Metabolism: clinical and experimental 1988;37(7):640-4.
1988: Jørgensen J O; Flyvbjerg A; Lauritzen T; Alberti K G; Orskov H; Christiansen J S
Dose-response studies with biosynthetic human growth hormone (GH) in GH-deficient patients.
The Journal of clinical endocrinology and metabolism 1988;67(1):36-40.
1988: Schmitz O; Arnfred J; Orskov L; Nielsen O H; Orskov H; Posborg V
Influence of hyperglycemia on glucose uptake and hepatic glucose production in non-dialyzed uremic patients.
Clinical nephrology 1988;30(1):27-34.
1988: Jørgensen J O; Flyvbjerg A; Lauritzen T; Orskov H; Christiansen J S
Subcutaneous degradation of biosynthetic human growth hormone in growth hormone deficient patients.
Acta endocrinologica 1988;118(1):154-8.
1988: Thuesen L; Christiansen J S; Schmitz O; Christensen N J; Orskov H; Henningsen P
Increased myocardial contractility during intravenous insulin infusion in type 1 (insulin-dependent) diabetic patients: an echocardiographic study.
Scandinavian journal of clinical and laboratory investigation 1988;48(3):275-84.
1988: Flyvbjerg A; Thorlacius-Ussing O; Naeraa R; Ingerslev J; Orskov H
Kidney tissue somatomedin C and initial renal growth in diabetic and uninephrectomized rats.
Diabetologia 1988;31(5):310-4.
1988: Thorlacius-Ussing O; Flyvbjerg A; Orskov H
Growth in young rats after termination of sodium selenite exposure: studies of growth hormone and somatomedin C.
Toxicology 1988;48(2):167-76.
1988: Thuesen L; Christiansen J S; Sørensen K E; Orskov H; Henningsen P
Low-dose intravenous glucagon has no effect on myocardial contractility in normal man. An echocardiographic study.
Scandinavian journal of clinical and laboratory investigation 1988;48(1):71-5.
1988: Thorlacius-Ussing O; Flyvbjerg A; Jørgensen K D; Orskov H
Growth hormone restores normal growth in selenium-treated rats without increase in circulating somatomedin C.
Acta endocrinologica 1988;117(1):65-72.
1988: Thuesen L; Christensen S E; Weeke J; Orskov H; Henningsen P
A hyperkinetic heart in uncomplicated active acromegaly. Explanation of hypertension in acromegalic patients?
Acta medica Scandinavica 1988;223(4):337-43.
1987: Jørgensen J O; Flyvbjerg A; Dinesen J; Lund H; Alberti K G; Orskov H; Christiansen J S
Serum profiles and short-term metabolic effect of pituitary and authentic biosynthetic human growth hormone in man. A double-blind cross-over study.
Acta endocrinologica 1987;116(3):381-6.
1987: Thuesen L; Christiansen J S; Schmitz O; Christensen N J; Orskov H; Henningsen P
Increased myocardial performance following acute hyperglycaemia in insulin-dependent diabetic patients. A consequence of increased peripheral blood flow?
Scandinavian journal of clinical and laboratory investigation 1987;47(6):571-9.
1987: Christensen S E; Weeke J; Orskov H; Møller N; Flyvbjerg A; Harris A G; Lund E; Jørgensen J
Continuous subcutaneous pump infusion of somatostatin analogue SMS 201-995 versus subcutaneous injection schedule in acromegalic patients.
Clinical endocrinology 1987;27(3):297-306.
1987: Christensen S E; Weeke J; Orskov H; Jørgensen J O; Esmann J; Doxey J C
Plasma growth hormone in acromegalic patients. Demonstration of highly reproducible diurnal profiles in individual patients.
Acta endocrinologica 1987;116(1):49-52.
1987: Schmitz O; Sorensen S S; Alberti K G; Orskov H; Hansen H E
Metabolic control in newly kidney transplanted insulin-dependent diabetics: improvement by insulin pump treatment (CSII).
The Journal of diabetic complications 1987;1(3):81-6.
1983: Sørensen K V; Christensen S E; Hansen A P; Pedersen E; Orskov H
Cerebrospinal fluid somatostatin inversely correlated with disease activity in multiple sclerosis.
Lancet 1983;1(8331):988.
1983: Christensen S E; Schmitz O; Hansen A P; Orskov H
The glucose sensor. Some results and applications.
Acta medica Scandinavica. Supplementum 1983;671():121-8.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Hans Orskov

Research Profile (preview)

Chemicals & Drugs

Living Beings

Anatomy

Disorders

Concepts & Ideas

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Hans Orskov (preview)

All Publications